Gastroenterology
Volume 129, Issue 3 , Pages 885-893, September 2005

Keratins as Susceptibility Genes for End-Stage Liver Disease

  • Nam–On Ku

      Affiliations

    • Department of Medicine, Palo Alto VA Medical Center, Palo Alto and Stanford University School of Medicine, Stanford, California
  • ,
  • Joseph K. Lim

      Affiliations

    • Department of Medicine, Palo Alto VA Medical Center, Palo Alto and Stanford University School of Medicine, Stanford, California
  • ,
  • Sheri M. Krams

      Affiliations

    • Department of Surgery, Palo Alto VA Medical Center, Palo Alto and Stanford University School of Medicine, Stanford, California
  • ,
  • Carlos O. Esquivel

      Affiliations

    • Department of Surgery, Palo Alto VA Medical Center, Palo Alto and Stanford University School of Medicine, Stanford, California
  • ,
  • Emmet B. Keeffe

      Affiliations

    • Department of Medicine, Palo Alto VA Medical Center, Palo Alto and Stanford University School of Medicine, Stanford, California
  • ,
  • Teresa L. Wright

      Affiliations

    • San Francisco VA Medical Center, San Francisco, California USAUniversity of California, San Francisco, California
  • ,
  • David A.D. Parry

      Affiliations

    • Massey University, Palmerston North, New Zealand
  • ,
  • M. Bishr Omary

      Affiliations

    • Department of Medicine, Palo Alto VA Medical Center, Palo Alto and Stanford University School of Medicine, Stanford, California
    • Corresponding Author InformationAddress requests for reprints to: Nam-On Ku, PhD, Palo Alto VA Medical Center, Mail Code 154J, 3801 Miranda Avenue, Palo Alto, California 94304. fax: (650) 852-3259.

Received 24 October 2004; accepted 26 May 2005.

Background & Aims: Keratins 8 and 18 protect the liver from stress. Keratin 8 and 18 variants in 17 of 467 liver disease explants and 2 of 349 blood bank controls were previously reported in 5 analyzed exonic regions. We asked whether mutations were present in the remaining 10 exons of keratins 8 and 18. Methods: Exonic regions were polymerase chain reaction–amplified from genomic DNA, isolated from the above-mentioned 2 cohorts, and analyzed for the presence of mutations. Mutant keratins were also studied biochemically. Results: We identified 10 novel keratin 8 and 18 heterozygous variants in 44 of 467 explants and 11 of 349 controls: keratin 18 deletion (Δ64–71), a keratin 8 frameshift that truncates the last 14 amino acids; 8 missense keratin 8 and 18 alterations; and several new polymorphisms. The most common variant, keratin 8 R340H, at the highly conserved R340 was found in 30 of 467 explants and 10 of 349 controls (P = .02) and was confirmed in the diseased livers by generation of an R340H-specific antibody. Germline transmission and variant protein expression were verified. The mutations involved a variety of liver diseases, and some variants had an ethnic background preponderance. Mutations that introduced disulfide bonds (keratin 8 G61C or R453C) decreased keratin solubility, particularly after oxidative stress, whereas others decreased keratin 8 phosphorylation (keratin 8 G433S). Conclusions: The overall frequency of keratin 8 and 18 variants was 12.4% in 467 liver disease explants and 3.7% in 349 blood bank controls (P < .0001). Variants can alter keratin solubility or phosphorylation and may render individuals susceptible to end-stage liver disease, depending on their genetic background and exposure to other insults, such as alcohol or viral infection.

Abbreviations used in this paper:  CI, confidence interval , K, keratin , MAPK, mitogen-activated protein kinase , OR, odds ratio , SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis , WT, wild type

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by VA Merit and National Institutes of Health (NIH) grant DK47918 awards (to M.B.O.), and NIH Digestive Disease Center grant DK56339. N.-O.K. is supported in part by a Veterans Administration Research Enhancement Award Program, and NIH DK56339 Pilot Award.

PII: S0016-5085(05)01353-3

doi:10.1053/j.gastro.2005.06.065

Gastroenterology
Volume 129, Issue 3 , Pages 885-893, September 2005